Northrop Grumman Corporation
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a NOC research report →
Range $430 – $745
Price Chart
About the company
Northrop Grumman Corporation is a leading global player in the aerospace and defense sectors. Its Aeronautics Systems division is responsible for the full lifecycle of aircraft, from design and development to production, integration, and ongoing maintenance. This includes a diverse portfolio of crewed and uncrewed aerial platforms: advanced strategic long-range strike aircraft, tactical fighter and air superiority jets, and sophisticated airborne systems for battle management and command and control.
- CEO
- Kathy J. Warden
- IPO
- 1981
- Employees
- 95,000
- HQ
- Falls Church, VA, US
Get TickerSpark's AI analysis on NOC
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $75.91B
- P/E
- 17.07
- Fwd P/E
- 18.00
- PEG
- 1.21
- P/S
- 1.77
- P/B
- 4.12
- EV/EBITDA
- 12.12
- Div Yield
- 1.77%
- Gross Margin
- 20.02%
- Op Margin
- 10.61%
- Net Margin
- 10.37%
- ROE
- 25.70%
- ROIC
- 10.30%
Latest fiscal year · YoY change
- Revenue
- $41.95B+2.2%
- Gross Profit
- $8.31B-0.6%
- Op Income
- $4.51B
- Net Income
- $4.18B+0.2%
- EPS
- $29.14+2.6%
- OCF Growth
- +8.4%
- FCF Growth
- +26.2%
- 52W High
- $774.00
- 52W Low
- $470.06
- 50D MA
- $522.88
- 200D MA
- $581.66
- Beta
- -0.11
- RSI (14)
- 53
- Avg Volume
- 925.67K
Earnings call summaries
Pick a quarter — each call distilled into takeaways, results, and a bull vs bear read.
Northrop Grumman delivered a strong third quarter with higher sales, margins, EPS, and backlog, and raised full-year profit and EPS guidance while signaling continued growth into 2027 and beyond.· October 20, 2026
- Backlog hit a record $110 billion, up 20%, on bookings of over $16 billion and a 1.5x book-to-bill.
- Q3 sales were $11.1 billion, up 7% year over year, with segment operating margin at 12.1% and EPS of $7.89, up 3%.
- Management raised full-year 2026 segment operating income guidance by $65 million and EPS guidance by $0.70, while keeping adjusted free cash flow at $3.1 billion to $3.5 billion.
- 2027 sales are expected to grow 5% to 7%, with management saying growth should accelerate further in 2028 and beyond.
- The company highlighted major program momentum in B-21, Sentinel, space, munitions, and a new microelectronics/commercial opportunity around Fortitude and quantum.
Third quarter sales were $11.1 billion, up 7% year over year. Segment operating income grew 5% with a 12.1% margin rate; prior-year comparison benefited from a favorable $68 million EAC adjustment at Mission Systems. Diluted EPS was $7.89, up 3%. Adjusted free cash flow was $1.8 billion, up over 40% year over year, helped by working capital and $371 million of proceeds from the sale of a test asset on the B-21 program. Backlog increased 20% to a record $110 billion on bookings of over $16 billion, with book-to-bill at 1.5 for the quarter and 1.45 year to date. For 2026, the company expects sales of $43.75 billion to $44.25 billion and a full-year book-to-bill of at least 1.3. Management raised segment operating income guidance to $4.94 billion to $5.04 billion and said the midpoint implies a full-year segment operating margin rate of approximately 11.3%. EPS guidance was increased by $0.70, driven by higher segment performance and a lower tax rate, partially offset by higher corporate unallocated cost and interest expense. Adjusted free cash flow guidance was maintained at $3.1 billion to $3.5 billion. For 2027, management projected sales growth of 5% to 7%, with segment operating income growing faster than sales, 10 to 20 basis points of margin expansion beyond the current 2026 midpoint, CapEx of about $2.1 billion, and adjusted free cash flow of $3.3 billion to $3.7 billion.
Kathy Warden framed the quarter as evidence that Northrop is executing well across a portfolio aligned to national security priorities. She emphasized the company’s strategy of innovation, performance, and disciplined capital deployment, and pointed to durable growth drivers in B-21, Sentinel, space, munitions, and international demand. Her tone was confident and forward-looking, especially around using defense technologies like microelectronics and quantum as potential commercial growth vectors.
John Greene highlighted broad-based financial strength: sales up 7%, segment operating income up 5%, EPS up 3%, and adjusted free cash flow up more than 40% year over year. He said the company is increasing 2026 segment operating income and EPS guidance while maintaining full-year free cash flow, and he pointed to continued strong awards, margin execution, and tax optimization. On 2027, he said sales should grow 5% to 7%, CapEx should rise to about $2.1 billion, and cash flow should improve to $3.3 billion to $3.7 billion despite higher B-21-related investment.
Analysts focused on what drives the 2027 growth range, what could pull 2028 growth forward, and how much visibility exists into longer-term acceleration. Management said the low end of the 2027 range reflects where they are in their own planning and budget cycle, while the high end depends on continued strong execution, more contracts getting on award, and the timing of appropriations and international awards. They also said B-21, Sentinel, munitions, and restricted space are key growth contributors, and that 2028 should be higher than 2027, though they did not give a specific number. Another cluster of questions addressed the new Fortitude microelectronics technology and the broader quantum/foundry strategy; Warden said all options are on the table, including continued internal investment, broader investment partnerships, or separation, but it is too early to quantify required capital.
The call showed strong operating momentum, with record backlog, higher margins, and management raising profit and EPS guidance. Northrop also sees a visible runway from major programs already under way, plus new opportunities in counter-UAS, microelectronics, quantum, and international defense demand.
The company acknowledged that 2027 growth visibility still depends on contract timing, appropriations, and how quickly programs move from development to production. Management also noted margin pressure from the mix shift as B-21 becomes a larger part of sales, higher capital spending for B-21 acceleration, and that the quantum initiative still requires strategic decisions and could require additional investment.
AI summary of the company's earnings call · Paraphrased · Not investment advice
- Free Float
- 99.7%
- Shares Outstanding
- 142.06M
- Float Shares
- 141.61M
of shares held by institutions
1,882 13F filers
Buy/sell ratio 0.14. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.
Congressional trading
Senate and House stock disclosures for NOC, newest first.
| Member | Type | Traded | |
|---|---|---|---|
| Alan ArmstrongSenate | Buy | Mar 27, 26 | Filing → |
| William R. KeatingHouse · MA09 | Buy | May 8, 26 | Filing → |
| Stephen CohenHouse · TN09 | Sell | Dec 29, 25 | Filing → |
| Val HoyleHouse · OR04 | Sell | Sep 23, 25 | Filing → |
| Gilbert CisnerosHouse · CA31 | Sell | Sep 5, 25 | Filing → |
| Sheri BiggsHouse · SC03 | Sell | Mar 19, 25 | Filing → |
| Val HoyleHouse · OR04 | Buy | Oct 29, 24 | Filing → |
| Ritchie TorresHouse · NY15 | Sell | Jul 11, 25 | Filing → |
| Ritchie TorresHouse · NY15 | Buy | Sep 26, 24 | Filing → |
| Lisa C. McClainHouse · MI09 | Sell | Jun 24, 25 | Filing → |
| Lisa C. McClainHouse · MI09 | Buy | Jun 17, 25 | Filing → |
| Robert P. BresnahanHouse · PA08 | Sell | May 15, 25 | Filing → |
| Gilbert CisnerosHouse · CA31 | Buy | May 30, 25 | Filing → |
| Josh GottheimerHouse · NJ05 | Sell | Apr 9, 25 | Filing → |
Source: public STOCK Act disclosures. Filed weeks after the trade — a lagging signal, not a real-time one.
Top institutional holders
Largest 13F positions, with quarter-over-quarter change.
| Holder | Shares | Δ Quarter |
|---|---|---|
| Vanguard Group Inc | 13.74M | ▲ 209.13K |
| State Street Corp | 13.27M | ▲ 99.22K |
| Blackrock, Inc. | 11.57M | ▼ 218.23K |
| Vanguard Capital Management LLC | 9.02M | ▲ 19.20K |
| Capital International Investors | 5.45M | ▼ 398.21K |
| Wellington Management Group Llp | 4.93M | ▼ 37.88K |
| Capital World Investors | 3.79M | ▼ 1.27M |
| Vanguard Portfolio Management LLC | 3.71M | ▲ 119.92K |
| Morgan Stanley | 3.60M | ▲ 36.65K |
| Franklin Templeton Inc | 3.59M | ▲ 213.19K |
| Geode Capital Management, LLC | 3.33M | ▲ 69.05K |
| Bank Of America Corp | 2.55M | ▼ 96.04K |
Held by 1,386 ETFs
Biggest fund positions in NOC by dollar value.
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Nov 2, 26 | Davies Benjamin R. | other | 641 |
| Nov 2, 26 | Davies Benjamin R. | other | 641 |
| Nov 2, 26 | Davies Benjamin R. | other | 281 |
| Nov 2, 26 | WELSH MARK A III | sell | 7 |
| Nov 2, 26 | WELSH MARK A III | sell | 20 |
| Nov 2, 26 | WELSH MARK A III | sell | 20 |
| Nov 2, 26 | WELSH MARK A III | sell | 50 |
| Nov 2, 26 | WELSH MARK A III | sell | 1 |
| Feb 12, 26 | Grady Christopher W. | other | 0 |
| Sep 30, 26 | KRISHNA ARVIND | other | 75 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our NOC coverage
Recent articles, reports, and earnings notes.

Howmet's (HWM) 7.5% plunge is the aerospace dip buyers were waiting for
Howmet's sharp decline looks more like a valuation reset than a breakdown in aerospace demand. Q2 revenue surged 24%, full-year guidance moved higher, and eight consecutive earnings beats keep the dip-buying case intact.

Defense's next leg belongs to backlog, not headlines
Geopolitical risk is lifting defense spending, but the sector is not a blanket buy. The better trade is concentrated in contractors with measurable backlog, missile, air-defense and ISR demand.

Europe's defense boom is real, but the stocks are pricing a perfect procurement cycle
NATO's spending commitments create a genuine multiyear demand tailwind, but defense stocks are already valued for smooth, immediate budget conversion. The key question is which contractors can turn fragmented national programs into durable cash flow without sacrificing margins.
Want a deeper read on NOC?
Generate a full analyst-grade report — bull/bear case, price targets, valuation depth, and a complete financial breakdown.
The Pentagon Keeps Spending. These 4 Defense Stocks Keep Raising Their Dividends
247wallst.com · Nov 20
Northrop Grumman (NOC) Up 0.7% Since Last Earnings Report: Can It Continue?
zacks.com · Nov 19
3 Defense Dividend Stocks to Buy in December With Billions in Backlogged Orders
247wallst.com · Nov 19
Northrop Grumman Board Declares Quarterly Dividend
globenewswire.com · Nov 18
Can Rising PAC-3 Demand Drive Northrop Grumman's Growth?
zacks.com · Nov 17
Northrop Grumman Lands $1.6 Billion Award to Scale PAC-3 MSE Propulsion Production
globenewswire.com · Nov 16
3 Dividend Stocks That Don’t Need a Booming Economy to Keep Paying
247wallst.com · Nov 16
Amazon Just Lost 40 Leo Satellites. The Bigger Problem Is the Rocket It Booked 38 Launches On
247wallst.com · Nov 16
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.